Back

Decreasing albumin within normal range is associated with increased likelihood of ischemic heart disease

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardiovascular risk assessment - Biomarkers 1 Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Elad Maor

Sheba Medical Center, Tel Aviv (Israel)

7 More presentations in this session

Presentation thumbnail
Lp(a) is not associated with arterial stiffness: A Mendelian Randomization Study.
Doctor E. Maneta (Salt Lake City, US)
Abstract Slides
Presentation thumbnail
Investigation of type 1 collagen a1 chain in plasma as a potential novel biomarker for prediction of coronary heart disease
Mr F. Hammareus (Linkoping, SE)
Abstract Slides
Presentation thumbnail
Clinical significance of undetectable high sensitivity cardiac troponin I (hs-TnI) in Thai individuals with low cardiovascular risk.
Ms P. Sabkaewyod (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Physical activity during adolescence and early adulthood and adult cardiometabolic risk profile: a longitudinal study
Mrs S. Sondergaard (Herning, DK)
Abstract Slides
Presentation thumbnail
Trans fatty acid blood levels and HFpEF phenotype: from the Aldo-DHF RCT
Doctor K. Lechner (Munich, DE)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular risk assessment - Biomarkers 1

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources